Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review

GlobalData
July 30, 2014
16 Pages - SKU: GBDT5318808
Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review

provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations.

The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Napp Pharmaceuticals Limited (Napp Pharmaceuticals) carries out the research, development and production of drugs in various therapeutic areas. It principally focuses on the pain management area. The company develops and markets products in various therapeutic areas including oncology, respiratory, rheumatology, cardiovascular and constipation. It is also expanding its operations into other therapeutic areas which are in clinical trials phase. Napp Pharmaceuticals has extensive expertise in prolonged release technology to reduce the dosing frequency for patients. The company is part of a worldwide association of independent pharmaceutical companies.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.



More Pharmaceuticals Company reports by GlobalData

PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies by GlobalData
PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical CompaniesSummaryThe Global Pharmaceutical Market Benchmark Report applies GlobalData’s proprietary ranking ...
Kuros Biosurgery AG - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryKuros Biosurgery AG (Kuros) is a medical technology company. The company develops biologic and biomaterial-based products for the spine, trauma and wound care. Its wound ...
Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review by GlobalData
Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The ...
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review by GlobalData
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 125  
    Site License  USD 250  
    Global Site License  USD 375  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!